
ViewRay
Advanced radiation therapy technology for the treatment of cancer.
Market cap
$975
Enterprise value
$824
Share price
$0.00 VRAY
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
* | $125m | Post IPO Debt | |
Total Funding | 000k |

OrbiMed(exited)

F-Prime(exited)

Aisling Capital(exited)
Next47(exited)

Hercules Capital(exited)

CRG LP(exited)

Eight Roads Ventures(exited)

Montrose Capital Partners(exited)

Armentum Partners(exited)

Technology Ventures(exited)

Centre for Genomic Regulation(exited)

Fidelity Investments(exited)

Kearny Venture Partners(exited)

Xeraya Capital(exited)

Elekta AB(exited)

Puissance Capital(exited)
USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 138 % | 9 % | (35 %) | 23 % | 46 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (135 %) | (83 %) | (123 %) | (174 %) | (140 %) | (98 %) |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (212 %) | (94 %) | (136 %) | (189 %) | (157 %) | (105 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.